T:Slim less burden for children with T1
Trial data reveals that children with Type 1 diabetes using a hybrid closed-loop system and their parents do not report an increase in diabetes-related burden
Trial data reveals that children with Type 1 diabetes using a hybrid closed-loop system and their parents do not report an increase in diabetes-related burden
The U.S. Food and Drug Administration (FDA) has approved the t:slim X2 insulin pump with Basal-IQ technology from Tandem Diabetes Care. Basal-IQ is a predictive
Tandem Diabetes Care, the medical device company and manufacturer of the only touchscreen insulin pumps available in the US has entered into a distribution agreement